US FDA’s Push For Greater Transparency: What About Advisory Committees?

Advisory committee meetings allowed the FDA to be more transparent about its concerns with applications under review. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US Advisory Committees

More from United States